Toxoplasmosis

Lancet

Volumn 363, Issue 9425, 2004, Pages 1965-1976

  Montoya, J G ^a,b   Liesenfeld, O ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PALO ALTO MEDICAL FOUNDATION RESEARCH INSTITUTE   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; DAPSONE; FOLINIC ACID; PREDNISONE; PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN; TRIMETHOPRIM;

CLINICAL FEATURE; CONFERENCE PAPER; CONGENITAL INFECTION; DENDRITIC CELL; DISEASE TRANSMISSION; EATING; ENCEPHALITIS; EYE DISEASE; FLUID INTAKE; FOOD CONTAMINATION; FOOD INTAKE; HUMAN; IMMUNE DEFICIENCY; INFECTION PREVENTION; MEAT; NEUROLOGIC EXAMINATION; OOCYST; ORGAN TRANSPLANTATION; PREGNANT WOMAN; PRIMARY INFECTION; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTOZOON; RISK ASSESSMENT; SECONDARY PREVENTION; SEROPREVALENCE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 2942541583     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16412-X     Document Type: Conference Paper

References (143)

1. Cornelissen AW, Overdulve JP, van der Ploeg M. Determination of nuclear DNA of five eucoccidian parasites, Isospora (Toxoplasma) gondii, Sarcocystis cruzi, Eimeria tenella, E acervulina and Plasmodium berghei with special reference to gamontogenesis and meiosis in I. (T.) gondii. Parasitology. 88:1984;531-553
2. Frenkel JK. Toxoplasmosis: parasite life cycle pathology and immunology. Hammond DM, Long PL. The Coccidia. 1973;343-410 University Park Press, Baltimore
3. Dubey JP, Miller NL, Frenkel JK. The Toxoplasma gondii oocyst from cat feces. J Exp Med. 132:1970;636-662
4. Dobrowolski JM, Sibley LD. Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell. 84:1996;933-939
5. Sibley LD, Boothroyd JC. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature. 359:1992;82-85
6. Howe DK, Sibley DL. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis. 172:1995;1561-1566
7. Ajzenberg D, Cogne N, Paris L, et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis. 186:2002;684-689
8. Kong JT, Grigg ME, Uyetake L, Parmley S, Boothroyd JC. Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. J Infect Dis. 187:2003;1484-1495
9. Grigg ME, Bonnefoy S, Hehl AB, Suzuki Y, Boothroyd JC. Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries. Science. 294:2001;161-165
10. Su C, Evans D, Cole RH, Kissinger JC, Ajioka JW, Sibley LD. Recent expansion of Toxoplasma through enhanced oral transmission. Science. 299:2003;414-416
11. Fox BA, Bzik DJ. De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii. Nature. 415:2002;926-929
12. Meissner M, Schluter D, Soldati D. Role of Toxoplasma gondii myosin A in powering parasite gliding and host cell invasion. Science. 298:2002;837-840
13. Desmonts G, Couvreur J, Alison F, Baudelot J, Gerbeaux J, Lelong M. Etude epidemiologique sur la toxoplasmose: l'influence de la cuisson des viandes de boucherie sur la frequence de l'infectin humaine. Rev Fr Etud Clin Biol. 10:1965;952-958
14. Cook AJ, Gilbert RE, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. BMJ. 321:2000;142-147
15. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. Remington JS, Klein J. Infectious diseases of the fetus and newborn infant. 5th edn:2001;205-346 WB Saunders, Philadelphia
16. Dubey JP, Gamble HR, Hill D, Sreekumar C, Romand S, Thuilliez P. High prevalence of viable Toxoplasma gondii infection in market weight pigs from a farm in Massachusetts. J Parasitol. 88:2002;1234-1238
17. Teutsch SM, Juranek DD, Sulzer A, Dubey JP, Sikes RK. Epidemic toxoplasmosis associated with infected cats. N Engl J Med. 300:1979;695-699
18. Bowie WR, King AS, Werker DH, et al. Outbreak of toxoplasmosis associated with municipal drinking water. Lancet. 350:1997;173-177
19. Bahia-Oliveira LM, Jones JL, Azevedo-Silva J, Alves CC, Orefice F, Addiss DG. Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerg Infect Dis. 9:2003;55-62
20. Brooks RG, Remington JS. Transplant-related infections. Bennett JV, Brachman PS. Hospital infections. 2nd edn:1986;581-618 Little, Brown and Co, Boston
21. Israelski DM, Remington JS. Toxoplasmosis in the non-AIDS immunocompromised host. Remington J, Swartz M. Current clinical topics in infectious diseases. 1993;322-356 Blackwell Scientific Publications, London
22. Raisanen SA. The importance of trophozoites in transmission of toxoplasmosis: survival and pathogenity of Toxoplasma gondii trophozoites in liquid media. Med Hypotheses. 4:1978;367-375
23. Siegel SE, Lunde MN, Gelderman AH, et al. Transmission of toxoplasmosis by leukocyte transfusion. Blood. 37:1971;388-394
24. Kayhoe DE, Jacobs L, Beye HK, McCullough NB. Acquired toxoplasmosis: observations on two parasitologically proved cases treated with pyrimethamine and triple sulfonamides. N Engl J Med. 257:1957;1247-1254
25. Remington JS, Gentry LO. Acquired toxoplasmosis: infection versus disease. Ann NY Acad Sci. 174:1970;1006-1017
26. Guerina N, Hsu H-W, Meissner H, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med. 330:1994;1858-1863
27. Jenum PA, Stray-Pedersen B, Melby KK, et al. Incidence of Toxoplasma gondii infection in 35, 940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol. 36:1998;2900-2906
28. Lebech M, Andersen O, Christensen NC, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet. 353:1999;1834-1837
29. Gavinet MF, Robert F, Firtion G, et al. Congenital toxoplasmosis due to maternal reinfection during pregnancy. J Clin Microbiol. 35:1997;1276-1277
30. Vogel N, Kirisits M, Michael E, et al. Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception. Clin Infect Dis. 23:1996;1055-1060
31. Hohlfeld P, Daffos F, Costa J-M, Thuylliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with polymerase-chain-reaction test on amniotic fluid. N Engl J Med. 331:1994;695-699
32. Romand S, Wallon M, Franck J, Thulliez P, Peyron F, Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol. 97:2001;296-300
33. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet. 353:1999;1829-1833
34. Daffos F, Forestier F, Capella-Pavlovsky M, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med. 318:1988;271-275
35. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics. 66:1980;767-774
36. Wallon M, Liou C, Garner P, Peyron F. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ. 318:1999;1511-1514
37. European Collaborative Study and Research Network on Congenital Toxoplasmosis. Low incidence of congenital toxoplasmosis in children born to women infected with human immunodeficiency virus. Eur J Obstet Gynecol Reprod Biol. 68:1996;93-96
38. Minkoff H, Remington JS, Holman S, Ramirez R, Goodwin S, Landesman S. Vertical transmission of toxoplasma by human immunodeficiency virus-infected women. Am J Obstet Gynecol. 176:1997;555-559
39. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol. 154:2001;357-365
40. Forsgren M, Gille E, Ljungstrom I, Nokes DJ. Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987. Lancet. 337:1991;1413-1414
41. Smith KL, Wilson M, Hightower AW, et al. Prevalence of Toxoplasma gondii antibodies in US military recruits in 1989: comparison with data published in 1965. Clin Infect Dis. 23:1996;1182-1183
42. Aspock H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl. 84:1992;32-37
43. Liesenfeld O. Immune responses to Toxoplasma gondii in the gut. Immunobiology. 201:1999;229-239
44. Su C, Howe DK, Dubey JP, Ajioka JW, Sibley LD. Identification of quantitative trait loci controlling acute virulence in Toxoplasma gondii. Proc Natl Acad Sci USA. 99:2002;10753-10758
45. Suzuki Y, Wong S-Y, Grumet FC, et al. Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J Infect Dis. 173:1996;265-268
46. Roberts C, Cruickshank S, Alexander J. Sex-determined resistance to Toxoplasma gondii is associated with temporal differences in cytokine production. Infect Immun. 63:1995;2549-2555
47. Barragan A, Sibley LD. Transepithelial migration of Toxoplasma gondii is linked to parasite motility and virulence. J Exp Med. 195:2002;1625-1633
48. Morrissette NS, Sibley LD. Cytoskeleton of apicomplexan parasites. Microbiol Mol Biol Rev. 66:2002;21-38
49. Karsten V, Qi H, Beckers CJ, et al. The protozoan parasite Toxoplasma gondii targets proteins to dense granules and the vacuolar space using both conserved and unusual mechanisms. J Cell Biol. 141:1998;1323-1333
50. Shaw MK, Roos DS, Tilney LG. Acidic compartments and rhoptry formation in Toxoplasma gondii. Parasitology. 117:(Pt 5):1998;435-443
51. Nielsen H, Christiansen L, Buus S, Fomsgaard A, Petersen E, Lauemoller S. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun. 67:1999;6358-6363
52. Bhopale GM. Development of a vaccine for toxoplasmosis: current status. Microbes Infect. 5:2003;457-462
53. + gut intraepithelial lymphocytes, lytic for parasite-infected enterocytes. J Immunol. 153:1994;4596-4603
54. Reis e Sousa C, Hieny S, Scharton-Kersten T, et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med. 198:1997;1819-1829
55. Bliss SK, Marshall AJ, Zhang Y, Denkers EY. Human polymorphonuclear leukocytes produce IL-12, TNF-alpha, and the chemokines macrophage-inflammatory protein-1 alpha and -1 beta in response to Toxoplasma gondii antigens. J Immunol. 162:1999;7369-7375
56. Denkers EY, Gazzinelli RT. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev. 11:1998;569-588
57. Luder CG, Lang T, Beuerle B, Gross U. Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Clin Exp Immunol. 112:1998;308-316
58. Luder CG, Lang C, Giraldo-Velasquez M, Algner M, Gerdes J, Gross U. Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA. J Neuroimmunol. 134:2003;12-24
59. Nash PB, Purner MB, Leon RP, Clarke P, Duke RC, Curiel TJ. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J Immunol. 160:1998;1824-1830
60. Montoya JG, Lowe KE, Clayberger C, et al. Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells. Infect Immun. 64:1996;176-181
61. Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science. 240:1988;516-518
62. Scalise F, Gerli R, Castellucci G, et al. Lymphocytes bearing the γδ T-cell receptor in acute toxoplasmosis. Immunology. 76:1992;668-670
63. de Paoli P, Basaglia G, Gennari D, Crovatto M, Modolo M, Santini G. Phenotypic profile and functional characteristics of human gamma and delta t cells during acute toxoplasmosis. J Clin Microbiol. 30:1992;729-731
64. Chardes T, Bourguin I, Mevelec M-N, Dubremetz J-F, Bout D. Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens. Infect Immun. 58:1990;1240-1246
65. Mineo J, McLeod R, Mack D, et al. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection. J Immunol. 150:1993;3951-3964
66. Dorfman RF, Remington JS. Value of lymph-node biopsy in the diagnosis of acute acquired toxoplasmosis. N Engl J Med. 289:1973;878-881
67. Weiss L, Chen Y, Berry G, Strickler J, Dorfman R, Warnke R. Infrequent detection of Toxoplasma gondii genome in toxoplasmic lymphadenitis: a polymerase chain reaction study. Hum Pathol. 23:1992;154-158
68. Holland GN, O'Connor GR, Belfort R Jr, Remington JS. Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular infection and immunity. St. Louis: Mosby Yearbook, 1996: 1183-1223.
69. Montoya JG, Jordan R, Lingamneni S, Berry GB, Remington JS. Toxoplasmic myocarditis and polymyositis in patients with acute acquired toxoplasmosis diagnosed during life. Clin Infect Dis. 24:1997;676-683
70. Luft BJ, Conley F, Remington JS, et al. Outbreak of central-nervous- system toxoplasmosis in western Europe and North America. Lancet. 1:1983;781-784
71. Frenkel JK. Pathology and pathogenesis of congenital toxoplasmosis. Bull N Y Acad Med. 50:1974;182-191
72. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 15:1992;211-222
73. Mariuz P, Bosler EM, Luft BJ. Toxoplasma pneumonia. Semin Respir Infect. 12:1997;40-43
74. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 185:(suppl 1):2002;S73-82
75. Montoya JG, Remington JS. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis. 23:1996;277-282
76. Holland GN. Reconsidering the pathogenesis of ocular toxoplasmosis. Am J Ophthalmol. 128:1999;502-505
77. Burnett AJ, Shortt SG, Isaac-Renton J, King A, Werker D, Bowie WR. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology. 105:1998;1032-1037
78. Liesenfeld O, Wong SY, Remington JS. Toxoplasmosis in the setting of AIDS. Bartlett JG, Merigan TC, Bolognesi D. Textbook of AIDS medicine. 2nd edn:1999;225-259 Williams & Wilkins, Baltimore
79. Porter SB, Sande M. Toxoplasmosis of the central nervous system in the Acquired Immunodeficiency Syndrome. N Engl J Med. 327:1992;1643-1648
80. Luft BJ, Hafner R, Korzun AH, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med. 329:1993;995-1000
81. Gay-Andrieu F, Marty P, Pialat J, Sournies G, Drier de Laforte T, Peyron F. Fetal toxoplasmosis and negative amniocentesis: necessity of an ultrasound follow-up. Prenat Diagn. 23:2003;558-560
82. McAuley J, Boyer KM, Patel D, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clin Infect Dis. 18:1994;38-72
83. Swisher CN, Boyer K, McLeod R. Congenital toxoplasmosis. Semin Pediatr Neurol. 1:1994;4-25
84. Cazenave J, Cheyrou A, Blouin P. Use of polymerase chain reaction to detect Toxoplasma. J Clin Pathol. 44:1991;1037
85. Fuentes I, Rodriguez M, Domingo CJ, Del Castillo F, Juncosa T, Alvar J. Urine sample used for congenital toxoplasmosis diagnosis by PCR. J Clin Microbiol. 34:1996;2368-2371
86. Sabin AB, Feldman HA. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoan parasite (toxoplasma). Science. 108:1948;660-663
87. Walton BC, Benchoff BM, Brooks WH. Comparison of the indirect fluorescent antibody test and methylene blue dye test for detection of antibodies to Toxoplasma gondii. Am J Trop Med Hyg. 15:1966;149-152
88. Balsari A, Poli G, Molina V, et al. ELISA for toxoplasma antibody detection: a comparison with other serodiagnostic tests. J Clin Pathol. 33:1980;640-643
89. Hedman K, Lappalainen M, Seppala I, Makela O. Recent primary Toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis. 159:1989;736-739
90. Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis. 183:2001;1248-1253
91. Montoya JG, Liesenfeld O, Kinney S, Press C, Remington JS. VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J Clin Microbiol. 40:2002;2504-2508
92. Dannemann BR, Vaughan WC, Thulliez P, Remington JS. Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol. 28:1990;1928-1933
93. Jenum PA, Stray-Pedersen B, Gundersen A-G. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G activity. J Clin Microbiol. 35:1997;1972-1977
94. Lappalainen M, Koskela P, Koskiniemi M, et al. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis. 167:1993;691-697
95. Liesenfeld O, Press C, Montoya JG, et al. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia toxo IgM test. J Clin Microbiol. 35:1997;174-178
96. Naot Y, Desmonts G, Remington JS. IgM enzyme-linked immunosorbent assay test for the diagnosis of congenital Toxoplasma infection. J Pediatr. 98:1981;32-36
97. Siegel JP, Remington JS. Comparison of methods for quantitating antigen-specific immunoglobulin M antibody with a reverse enzyme-linked immunosorbent assay. J Clin Microbiol. 18:1983;63-70
98. Wilson M, Remington JS, Clavet C, et al. Evaluation of six commercial kits for detection of human immunoglobulin M antibiodies to Toxoplasma gondii. J Clin Microbiol. 35:1997;3112-3115
99. Montoya JG, Remington JS. Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin Infect Dis. 20:1995;781-790
100. Roberts A, Hedman K, Luyasu V, et al. Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis. 20:2001;467-474
101. Desmonts G, Naot Y, Remington JS. Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired Toxoplasma infections. J Clin Microbiol. 14:1981;486-491
102. Stepick-Biek P, Thulliez P, Araujo FG, Remington JS. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis. 162:1990;270-273
103. Decoster A, Slizewicz B, Simon J, et al. Platelia-toxo IgA, a new kit for early diagnosis of congenital toxoplasmosis by detection of anti-P30 immunoglobulin A antibodies. J Clin Microbiol. 29:1991;2291-2295
104. Pinon JM, Dumon H, Chemla C, et al. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol. 39:2001;2267-2271
105. Wong SY, Hadju M-P, Ramirez R, Thulliez P, McLeod R, Remington JS. The role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis. J Clin Microbiol. 31:1993;2952-2959
106. Pinon JM, Toubas D, Marx C, et al. Detection of specific immunoglobulin E in Patients with toxoplasmosis. J Clin Microbiol. 28:1990;1739-1743
107. de Boer JH, Verhagen C, Bruinenberg M, et al. Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Opthalmol. 121:1996;650-658
108. Grover CM, Thulliez P, Remington JS, Boothroyd JD. Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol. 28:1990;2297-2301
109. Montoya JG, Parmley S, Liesenfeld O, Jaffe GJ, Remington JS. Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis. Ophthalmology. 106:1999;1554-1563
110. Brezin AP, Egwuagu CE, Burnier M, et al. Identification of Toxoplasma gondii in paraffin-embedded sections by the polymerase chain reaction. Am J Ophthalmol. 110:1990;599-604
111. Dupouy-Camet J, Lavareda de Souza L, Maslo C, et al. Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction. J Clin Microb. 31:1993;1866-1869
112. Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant. 29:2002;691-698
113. Costa JM, Ernault P, Gautier E, Bretagne S. Prenatal diagnosis of congenital toxoplasmosis by duplex real-time PCR using fluorescence resonance energy transfer hybridization probes. Prenat Diagn. 21:2001;85-88
114. Filisetti D, Gorcii M, Pernot-Marino E, Villard O, Candolfi E. Diagnosis of congenital toxoplasmosis: comparison of targets for detection of Toxoplasma gondii by PCR. J Clin Microbiol. 41:2003;4826-4828
115. Fardeau C, Romand S, Rao NA, et al. Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol. 134:2002;196-203
116. Hitt JA, Filice GA. Detection of Toxoplasma gondii parasitemia by gene amplification, cell culture, and mouse inoculation. J Clin Microbiol. 30:1992;3181-3184
117. Conley FK, Jenkins KA, Remington JS. Toxoplasma gondii infection of the central nervous system: use of the peroxidase-antiperoxidase method to demonstrate toxoplasma in formalin fixed, paraffin embedded tissue sections. Hum Pathol. 12:1981;690-698
118. Liesenfeld O, Montoya JG, Tathineni NJ, et al. Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers. Am J Obstet Gynecol. 184:2001;140-145
119. Wong S, Remington JS. Toxoplasmosis in pregnancy. Clin Infect Dis. 18:1994;853-862
120. Gilbert RE, Gras L, Wallon M, Peyron F, Ades AE, Dunn DT. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol. 30:2001;1303-1308
121. Gilbert R, Dunn D, Wallon M, et al. Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol. Epidemiol Infect. 127:2001;113-120
122. Foulon W, Villena I, Stray-Pedersen B, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol. 180:(2 Pt1):1999;410-415
123. Gilbert R, Gras L. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG. 110:2003;112-120
124. Thulliez P. Efficacy of prenatal treatment for toxoplasmosis: a possibility that cannot be ruled out. Int J Epidemiol. 30:2001;1315-1316
125. Gras L, Gilbert RE, Ades AE, Dunn DT. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol. 30:2001;1309-1313
126. Forestier F, Hohlfeld P, Sole Y, Daffos F. Prenatal diagnosis of congenital toxoplasmosis by PCR: extended experience. Prenat Diagn. 18:1998;407-409
127. Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 134:2002;102-114
128. Silveira C, Belfort R Jr, Muccioli C, et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 134:2002;41-46
129. Luft BJ, Billingham M, Remington JS. Endomyocardial biopsy in the diagnosis of toxoplasmic myocarditis. Transplant Proc. 18:1986;1871-1873
130. Montoya JG, Remington JS. Toxoplasma gondii. Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious diseases. 2000;2858-2888 Churchill Livingstone, Philadelphia
131. Torre D, Casari S, Speranza F, et al. Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Antimicrob Agents Chemother. 42:1998;1346-1349
132. Chirgwin K, Hafner R, Leport C, et al. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. Clin Infect Dis. 34:2002;1243-1250
133. Kaplan JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons, 2002: recommendations of the US Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep. 51:(RR-8):2002;1-52
134. Eskild A, Oxman A, Magnus P, Bjorndal A, Bakketeig LS. Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem? J Med Screen. 3:1996;188-194
135. Desmonts G. Prevention de la toxoplasmose: remarques sur l'experience poursuivie en France. Prog Clin Biol Res. 163B:1985;333
136. McCabe R, Remington JS. Toxoplasmosis: the time has come. N Engl J Med. 318:1988;313-315
137. Kimball AC, Kean BH, Fuchs F. Congenital toxoplasmosis: a prospective study of 4, 048 obstetric patients. Am J Obstet Gynecol. 111:1971;211-218
138. Petersen E, Eaton RB. Control of congenital infection with Toxoplasma gondii by neonatal screening based on detection of specific immunoglobulin M antibodies eluted from phenylketonuria filter-paper blood-spot samples. Acta Paediatr Suppl. 88:1999;36-39
139. Buxton D, Innes EA. A commercial vaccine for ovine toxoplasmosis. Parasitology. 110:1995;11-16
140. Bulow R, Boothroyd JC. Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. J Immunol. 147:1991;3496-3500
141. Petersen E, Nielsen HV, Christiansen L, Spenter J. Immunization with E coli produced recombinant T gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. Vaccine. 16:1998;1283-1289
142. Ismael AB, Sekkai D, Collin C, Bout D, Mevelec MN. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect Immun. 71:2003;6222-6228
143. Liesenfeld O, Remington JS. Toxoplasmosis. Martens M, Faro S, Soper D. Infectious diseases in women. 2001;57-79 WB Saunders, Philadelphia